Autologous Hematopoietic Stem Cells Are a Preferred Source to Generate Dendritic Cells for Immunotherapy in Multiple Myeloma Patients

In multiple myeloma (MM), dendritic cells (DCs), and their precursors are prone to malignant cell-mediated regulation of function leading to low efficacy of DC vaccine. DCs taken directly from MM patient's body or derived from monocytes are fewer in numbers and are also dysfunctional. Here, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Shinde, Prajakta, Melinkeri, Sameer, Santra, Manas Kumar, Kale, Vaijayanti, Limaye, Lalita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536579/
https://www.ncbi.nlm.nih.gov/pubmed/31164886
http://dx.doi.org/10.3389/fimmu.2019.01079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536579/
https://www.ncbi.nlm.nih.gov/pubmed/31164886
http://dx.doi.org/10.3389/fimmu.2019.01079

Ejemplares similares